Our Firm

IBD—High-Conviction Strategy Yields Superior Results For These Award-Winning Funds

Parnassus Fund Manager Robert Klaber discusses how high-conviction, bottom-up stock selection has benefitted the Parnassus Funds.

See the full story.

For current quarter-end standardized performance and disclosure information, please click here.

As of 03/31/2017, Allergan (AGN) represented 4.4% of the Parnassus Fund’s TNA, 3.5% of the Parnassus Core Equity Fund’s TNA, 1.1% of the Parnassus Fixed Income Fund’s TNA and 4.3% of the Parnassus Endeavor Fund’s TNA. Gilead Sciences Inc. (GILD) represented 4.2% of the Parnassus Fund’s TNA, 4.8% of the Parnassus Core Equity Fund’s TNA, 0.9% of the Parnassus Fixed Income Fund’s TNA, 8.2% of the Parnassus Endeavor’s Fund TNA and 4.7% of the Parnassus Asia Fund’s TNA. eBay (EBAY) represented 1.8% of the Parnassus Fund’s TNA and 2.9% of the Parnassus Mid Cap Fund’s TNA. IBM Corp. (IBM) represented 4.3% of the Parnassus Fund’s TNA and 4.0% of the Parnassus Endeavor Fund’s TNA. Progressive Corp. (PGR) represented 3.5% of the Parnassus Fund’s TNA and 1.3% of the Parnassus Fixed Income Fund’s TNA.